These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2564787)

  • 1. Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVA.
    Doran AR; Rubinow DR; Wolkowitz OM; Roy A; Breier A; Pickar D
    Biol Psychiatry; 1989 Feb; 25(4):431-9. PubMed ID: 2564787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.
    Doran AR; Labarca R; Wolkowitz OM; Roy A; Douillet P; Pickar D
    Arch Gen Psychiatry; 1990 Jun; 47(6):558-63. PubMed ID: 2350208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.
    Konicki PE; Owen RR; Litman RE; Pickar D
    Life Sci; 1991; 48(14):1411-6. PubMed ID: 2008157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.
    Scheepers FE; Gispen-de Wied CC; Westenberg HG; Kahn RS
    Neuropsychopharmacology; 2001 Oct; 25(4):468-75. PubMed ID: 11557160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.
    Pickar D; Owen RR; Litman RE; Konicki E; Gutierrez R; Rapaport MH
    Arch Gen Psychiatry; 1992 May; 49(5):345-53. PubMed ID: 1375019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Pickar D; Labarca R; Doran AR; Wolkowitz OM; Roy A; Breier A; Linnoila M; Paul SM
    Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between abnormal brainstem auditory-evoked potentials and subnormal CSF levels of HVA and 5-HIAA in first-episode schizophrenic patients.
    Lindström LH; Wieselgren IM; Klockhoff I; Svedberg A
    Biol Psychiatry; 1990 Sep; 28(5):435-42. PubMed ID: 1698468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
    J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMPI measures of impulsivity and depression correlate with CSF 5-HIAA and HVA in depression but not schizophrenia.
    Faustman WO; King RJ; Faull KF; Moses JA; Benson KL; Zarcone VP; Csernansky JG
    J Affect Disord; 1991 Aug; 22(4):235-9. PubMed ID: 1939932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopamine-serotonin relationship in clozapine response.
    Szymanski S; Lieberman J; Pollack S; Munne R; Safferman A; Kane J; Kronig M; Cooper T
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S85-9. PubMed ID: 7530378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
    Kahn RS; Davidson M; Knott P; Stern RG; Apter S; Davis KL
    Arch Gen Psychiatry; 1993 Aug; 50(8):599-605. PubMed ID: 7688208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment.
    Sharma RP; Javaid JI; Janicak PG; Davis JM; Faull K
    Biol Psychiatry; 1993 Aug; 34(3):128-34. PubMed ID: 8104508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of trifluoperazine on CSF and plasma HVA levels in schizophrenic subjects.
    Sharma R; Javaid JI; Janicak P; Comaty J; Davis JM; Faull K
    Am J Psychiatry; 1988 Nov; 145(11):1480-1. PubMed ID: 3189613
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma and CSF HVA before and after pharmacological treatment.
    Sharma R; Javaid JI; Janicak P; Faull K; Comaty J; Davis JM
    Psychiatry Res; 1989 Apr; 28(1):97-104. PubMed ID: 2740469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.
    Nikisch G; Baumann P; Kiessling B; Reinert M; Wiedemann G; Kehr J; Mathé AA; Piel M; Roesch F; Weisser H; Schneider P; Hertel A
    J Psychiatr Res; 2010 Sep; 44(12):754-9. PubMed ID: 20176367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and cerebrospinal fluid prolactin patterns during neuroleptic treatment in schizophrenic patients.
    Rimón R; Kampman R; Laru-Sompa R; Heikkilä L
    Pharmacopsychiatry; 1985 May; 18(3):252-4. PubMed ID: 4011674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia.
    Houston JP; Maas JW; Bowden CL; Contreras SA; McIntyre KL; Javors MA
    Psychiatry Res; 1986 Nov; 19(3):207-14. PubMed ID: 3797547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on dopamine metabolite in cerebrospinal fluid of schizophrenics and epilepsics].
    Jiang S; Chen X; Liao W
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):155-6. PubMed ID: 10681831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.
    Beuger M; van Kammen DP; Kelley ME; Yao J
    Neuropsychopharmacology; 1996 Jul; 15(1):75-86. PubMed ID: 8797194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.